Loading...
ROCO
4431
Market cap19mUSD
Nov 13, Last price  
16.90TWD
Name

Mytrex Health Technologies Inc

Chart & Performance

D1W1MN
ROCO:4431 chart
P/E
P/S
0.35
EPS
Div Yield, %
Shrs. gr., 5y
2.94%
Rev. gr., 5y
34.58%
Revenues
1.76b
+36.02%
398,421,0001,023,640,000291,623,0001,471,549,0001,292,969,0001,758,684,000
Net income
-82m
L+46.53%
9,318,000352,274,000-14,011,000-91,901,000-56,219,000-82,375,000
CFO
32m
P
59,912,000440,760,00013,286,00072,478,000-4,255,00031,630,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers thermal insulation products for glove, sock, shoe, hat, clothing material, and mask insulation material applications; and linen laundry and leasing, logistic, and medical supplies for hospitals. In addition, the company sells pharmaceuticals and medical hygiene materials; and manages medical clothing products. Mytrex Health Technologies, Inc. was founded in 1990 and is based in Taoyuan, Taiwan.
IPO date
Aug 30, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT